2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
11
Neoplasms
5
Parasomnias
4
Depression
3
Weight Loss
2
Tuberous Sclerosis
2
Smith-Magenis Syndrome
2
Sleep Wake Disorders
2
Polycystic Ovary Syndrome
2
Pain
2
Lung Neoplasms
2
Fatigue
2
Cachexia
2
Autism Spectrum Disorder
2
Anxiety Disorders
2
Angelman Syndrome
2
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Disorders, Circadian Rhythm
1
Relapsed Malignant Solid Tumor
1
Radiodermatitis
1
Radiation Injuries
1
Quality of Life
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm Metastasis
1
Melanoma
1
Leukoplakia, Oral
1
Keratosis, Actinic
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Sevoflurane
1
Propofol
1
Melatonin
1
Fentanyl
1
Atracurium
1
Antineoplastic Agents, Hormonal
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Female Breast Cancer
×
Melatonin
×
Clear all
NCT06696378
2024-11-20
MEXBSO
University of Valladolid
Phase NA
Recruiting
120 enrolled